Irritable Bowel Syndrome News

Nearly 7.5 million Americans are expected to reach their holiday destinations by plane this year — a daunting task for most individuals but even more challenging for those with gastrointestinal disorders.

FDA has eliminated the Risk Evaluation and Mitigation Strategy (REMS) programs for Lotronex (alosetron hydrochloride) and approved generics.

VANCOUVER, British Columbia — ChatGPT 4.0 had an overall accuracy of 80% in its answers to questions about irritable bowel syndrome, although the chatbot still missed some details or provided outdated information, according to research.

VANCOUVER, British Columbia — Continued Ibsrela therapy for 12 weeks enabled early nonresponders with irritable bowel syndrome and constipation to achieve a meaningful response, noted a presenter at the ACG Annual Scientific Meeting.

Titrated low-dose amitriptyline demonstrated effectiveness and tolerability as a second-line therapy for irritable bowel syndrome in primary care compared with placebo, a randomized study in the United Kingdom showed.

An app-based digital therapeutic was “largely effective” in reducing symptoms and improving quality of life, work productivity and health literacy among patients with irritable bowel syndrome, according to late-breaking data from UEG Week.

Case-control and cohort analyses showed dysphasia, gastroparesis, irritable bowel syndrome without diarrhea and constipation may be associated with an increased risk for Parkinson’s disease, according to research in Gut.

Children and adults with atopic dermatitis are at an increased risk for inflammatory bowel disease, ulcerative colitis and Chron’s disease, according to a study.

A nationwide survey of nearly 89,000 individuals estimated the prevalence of Rome IV irritable bowel syndrome in the U.S. to be 6.1% compared with 4.7% to 5.3% in previous reports, according to a cross-sectional study in Gastroenterology.

In this month’s issue, we are highlighting the important topic of multidisciplinary care of our gastroenterology patients.